Literature DB >> 2040888

Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs)

N Agrawal1.   

Abstract

Thirteen million individuals in the United States take nonsteroidal anti-inflammatory drugs (NSAIDs) chronically for the relief of pain and inflammation caused by arthritis and related conditions. NSAIDs are valuable and in many cases essential to the management of arthritis pain. Long-term use of NSAIDs, however, can cause gastrointestinal (GI) ulcers and potentially life-threatening ulcer complications. Factors such as older age (greater than or equal to 60 years), a history of peptic ulcer disease, concomitant corticosterid use, cigarette smoking, alcohol use, and high dose or multiple NSAID therapy can increase the risk of GI damage and complications in the chronic NSAID user. Physician awareness of these risk factors is crucial so that the benefits and hazards of NSAID therapy in high-risk patients can be properly weighed. When the decision is made to prescribe NSAIDs, despite the presence of risk factors for NSAID-induced ulcers, patients should be closely monitored, and, in some cases, effective prophylaxis should be initiated. This is especially important since NSAID-induced gastrointestinal ulcers can be asymptomatic, causing serious ulcer complications without warning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040888

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  4 in total

Review 1.  Misoprostol/NSAID fixed combinations. Help or hindrance in clinical practice?

Authors:  A Isdale; V Wright
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

2.  Cross-sectional analysis of retrospective case series of hospitalisations for gastropathy caused by non-steroidal anti-inflammatory treatment: risk factors and gastroprotection use.

Authors:  José Luis Marco Garbayo; Manuel Koninckx Cañada; Isabel Pérez Castelló; María Teresa Faus Soler; Rosa Fuster Torres; Mar Moncho Escrivà
Journal:  Eur J Hosp Pharm       Date:  2016-11-07

Review 3.  Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.

Authors:  Kok Ann Gwee; Vernadine Goh; Graca Lima; Sajita Setia
Journal:  J Pain Res       Date:  2018-02-14       Impact factor: 3.133

4.  Evaluation and assessment of prescribing patterns in elderly patients using two explicit criteria based screening tools: (The PRISCUS list and STOPP/START criteria).

Authors:  Irum Butool; Shabnam Nazir; Maryam Afridi; Syed Majid Shah
Journal:  Pak J Med Sci       Date:  2018 Nov-Dec       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.